Skye Bioscience Enters Into Equity Purchase Agreement For Up To $22 Million

Filing content

Skye Bioscience entered into a Securities Purchase Agreement with Redmile Biopharma to sell up to $22 million of common stock and will issue a warrant to purchase $5 million of common stock.